Christine Y. Malati

Echinacea purpurea Significantly Induces Cytochrome P450 3A Activity but Does Not Alter Lopinavir‐Ritonavir Exposure in Healthy Subjects

Scott R. Penzak, J. Kovacs, S. Penzak, 2010, Pharmacotherapy.

Influence of Panax ginseng on Cytochrome P450 (CYP)3A and P‐glycoprotein (P‐gp) Activity in Healthy Participants

J. Kovacs, S. Penzak, Jennifer D. Hunt, 2012, Journal of clinical pharmacology.

Lack of an Effect of Ritonavir Alone and Lopinavir‐Ritonavir on the Pharmacokinetics of Fenofibric Acid in Healthy Volunteers

J. Kovacs, M. McLaughlin, L. A. Gordon, 2016, Pharmacotherapy.

Long-acting, injectable antiretroviral therapy for the management of HIV infection: an update on a potential game-changer.

N. Rakhmanina, Christine Y. Malati, Benjamin R Phelps, 2015 .

Pursuing use of optimal formulations for paediatric HIV epidemic control – a look at the use of LPV/r oral pellets and oral granules

R. Golin, Christine Y. Malati, Benjamin R Phelps, 2019, Journal of the International AIDS Society.

The promise of paediatric dolutegravir

R. Golin, G. Siberry, Christine Y. Malati, 2021, Journal of the International AIDS Society.

Dealing with large-scale supply lines when introducing new regimens

J. Kuritsky, Christine Y. Malati, Sherif M. S. Mowafy, 2017, Current opinion in HIV and AIDS.

Implementation of a Global Health Equity fellowship established in partnership between an academic institution and governmental agency

Monica L. Miller, S. Pastakia, Christine Y. Malati, 2022, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Implementation and resource needs for long‐acting PrEP in low‐ and middle‐income countries: a scoping review

F. Bozzani, J. Zucker, M. Sobieszczyk, 2023, Journal of the International AIDS Society.